Skip to main content Skip to footer

Insights

Thought Leadership, Founder Perspectives, and Industry News and Press

Filter

287 Results Reset

Navion Neurosciences Announces the Closing of a $10.8 Million Seed Financing to Advance AI-Enabled Sodium Channel Therapeutics

Announcements Sep 9, 2026

Navion Neurosciences Announces the Closing of a $10.8 Million Seed Financing to Advance AI-Enabled Sodium Channel Therapeutics

Welcome Our New Entrepreneur in Residence: Dr. Kuldeep Neote

Announcements Aug 20, 2026

Welcome Our New Entrepreneur in Residence: Dr. Kuldeep Neote

BUILT… in a Barn

Founder Perspectives Aug 10, 2026

BUILT… in a Barn

From Graduate Lab to Growing Company

Founder Perspectives Aug 7, 2026

From Graduate Lab to Growing Company

From a Father’s Mission to a Founder’s Path: How Luminoah Grew from Idea to Company

Founder Perspectives Aug 7, 2026

From a Father’s Mission to a Founder’s Path: How Luminoah Grew from Idea to Company

CvilleBioHub Releases GO Virginia–Funded Talent Strategy to Prepare Workforce for Next Wave of Pharmaceutical Manufacturing Growth

News & Press Jun 26, 2026

CvilleBioHub Releases GO Virginia–Funded Talent Strategy to Prepare Workforce for Next Wave of Pharmaceutical Manufacturing Growth

Governor Glenn Youngkin Announces Luna Labs to Expand Research and Development Operations in Charlottesville

News & Press Jun 26, 2026

Governor Glenn Youngkin Announces Luna Labs to Expand Research and Development Operations in Charlottesville

Luna Labs Launches 3 Waves Venture Spinout to Commercialize Advanced Vestibular Stimulation Technology

Member News Jun 11, 2026

Luna Labs Launches 3 Waves Venture Spinout to Commercialize Advanced Vestibular Stimulation Technology

TearSolutions Receives FDA Orphan Drug and Fast Track Designations for Lacripep® in Neurotrophic Keratitis and Initiates Phase 2 Clinical Trial with First Patients Dosed

Member News Jun 8, 2026

TearSolutions Receives FDA Orphan Drug and Fast Track Designations for Lacripep® in Neurotrophic Keratitis and Initiates Phase 2 Clinical Trial with First Patients Dosed

Avant Genomics Secures $3M+ in Funding to Accelerate First-in-kind Automated Platform for Liquid Biopsy Sample Preparation

Industry News May 28, 2026

Avant Genomics Secures $3M+ in Funding to Accelerate First-in-kind Automated Platform for Liquid Biopsy Sample Preparation

Apply for Membership